Emara M, Sanfilippo F
Department of Pathology, Duke University, Durham, North Carolina 27710.
Transplantation. 1989 Feb;47(2):364-71. doi: 10.1097/00007890-198902000-00037.
Human suppressor T cells induced by autologous mixed lymphocyte reaction (AMLR) using fresh responder PBL from a renal transplant recipient and an autologous irradiated antidonor CTL line (EE-1) established from a biopsy of the patient's own allograft were studied for the production of suppressor factors. The suppressor cell lines propagated (designated TsEE) were capable of inhibiting the in vitro generation of proliferative and cytotoxic responses of responder cells from the recipient or other individuals who shared HLA-B7 with TsEE cells, regardless of the stimulatory cell phenotype. Coculture of TsEE cells with the autologous irradiated EE-1 inducer cell line in vitro yielded a soluble factor (designated TsEEF) capable of inhibiting the generation of MLR and CTL responses, as well as mitogen-induced proliferative responses to PHA and PWM in an HLA-unrestricted manner. TsEEF also inhibited the replication of lymphoblastoid T cell lines (Molt-4 and HSB) but not B cell lines (SB and JC-EBV) or PBL stimulated with the B cell mitogen LPS. Control supernatants obtained from each of the cells used to generate TsEE in AMLR (i.e., EE-PBL and the EE-1 line) cultured alone or together for 48 hr demonstrated no suppressive activity in any of these test systems. TsEEF was nontoxic for lymphoid cells, was nondialyzable (greater than 12kDa), did not act by interfering with IL-1 or IL-2 utilization, and was negative for TNF and IFN-gamma activity. Functionally, the suppressive activity of TsEEF was dose-dependent, did not shift MLR kinetics, and could be absorbed by T cells. T cells incubated with TsEEF for 4 hr were unresponsive to subsequent mitogen or MLR stimulation. These findings indicate that, whereas T suppressor cell lines propagated from the circulation of a stable renal transplant recipient demonstrate class I HLA restriction, the activity of their soluble products is not HLA-restricted, and functionally inhibits T cell proliferation.
利用肾移植受者新鲜的反应性外周血淋巴细胞(PBL)和从患者自身同种异体移植物活检建立的自体照射抗供体细胞毒性T淋巴细胞系(EE - 1)通过自体混合淋巴细胞反应(AMLR)诱导产生的人抑制性T细胞,对其抑制因子的产生进行了研究。增殖的抑制细胞系(命名为TsEE)能够抑制来自受者或与TsEE细胞共享HLA - B7的其他个体的反应性细胞的增殖和细胞毒性反应的体外产生,而不考虑刺激细胞的表型。TsEE细胞与自体照射的EE - 1诱导细胞系在体外共培养产生了一种可溶性因子(命名为TsEEF),该因子能够以HLA非限制性方式抑制混合淋巴细胞反应(MLR)和细胞毒性T淋巴细胞(CTL)反应的产生,以及对植物血凝素(PHA)和美洲商陆有丝分裂原(PWM)的有丝分裂原诱导的增殖反应。TsEEF还抑制淋巴母细胞样T细胞系(Molt - 4和HSB)的复制,但不抑制B细胞系(SB和JC - EBV)或由B细胞有丝分裂原脂多糖(LPS)刺激的外周血淋巴细胞(PBL)。从用于在AMLR中产生TsEE的每个细胞(即EE - PBL和EE - 1系)单独或一起培养48小时获得的对照上清液在任何这些测试系统中均未显示出抑制活性。TsEEF对淋巴细胞无毒,不可透析(大于12kDa),不通过干扰白细胞介素 - 1(IL - 1)或白细胞介素 - 2(IL - 2)的利用起作用,并且肿瘤坏死因子(TNF)和γ干扰素(IFN - γ)活性为阴性。在功能上,TsEEF的抑制活性是剂量依赖性的,不改变MLR动力学,并且可以被T细胞吸收。与TsEEF孵育4小时的T细胞对随后的有丝分裂原或MLR刺激无反应。这些发现表明,虽然从稳定的肾移植受者循环中增殖的抑制性T细胞系表现出I类HLA限制,但其可溶性产物的活性不受HLA限制,并且在功能上抑制T细胞增殖。